+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Nerve Stimulators Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • February 2021
  • Region: Global
  • TechNavio
  • ID: 5300870
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Peripheral Nerve Stimulators Market 2021-2025

The publisher has been monitoring the peripheral nerve stimulators market and it is poised to grow by $141.03 mn during 2021-2025 progressing at a CAGR of 5% during the forecast period. The report on peripheral nerve stimulators market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for peripheral nerve stimulators over oral medications and increasing aging population and rising nerve injury cases. In addition, high demand for peripheral nerve stimulators over oral medications is anticipated to boost the growth of the market as well.

The peripheral nerve stimulators market analysis includes product segment and geographical landscapes.

The peripheral nerve stimulators market is segmented as below:

By Product
  • Transcutaneous
  • Percutaneous
  • Implantable

By Type
  • PNS-TOF
  • PNS

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing prevalence of neurologic disorders as one of the prime reasons driving the peripheral nerve stimulators market growth during the next few years.

Thereport on peripheral nerve stimulators market covers the following areas:
  • Peripheral nerve stimulators market sizing
  • Peripheral nerve stimulators market forecast
  • Peripheral nerve stimulators market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peripheral nerve stimulators market vendors that include Abbott Laboratories, Avanos Medical Inc., B. Braun Melsungen AG, Bioness Inc., Boston Scientific Corp., Medtronic Plc, PAJUNK GmbH Medical Technology, SPR Therapeutics Inc., SunMed LLC, and Xavant Technology Pty Ltd.. Also, the peripheral nerve stimulators market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Transcutaneous - Market size and forecast 2020-2025
  • Percutaneous - Market size and forecast 2020-2025
  • Implantable - Market size and forecast 2020-2025
  • Market opportunity by Product

Market Segmentation by Stimulating Feature
  • Market segments
  • Comparison by Stimulating Feature
  • PNS-TOF - Market size and forecast 2020-2025
  • PNS - Market size and forecast 2020-2025
  • Market opportunity by Stimulating Feature

Customer landscape
  • Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Bioness Inc.
  • Boston Scientific Corp.
  • Medtronic Plc
  • PAJUNK GmbH Medical Technology
  • SPR Therapeutics Inc.
  • SunMed LLC
  • Xavant Technology Pty Ltd.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Key Finding 9
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Transcutaneous - Market size and forecast 2020-2025 ($ million)
  • Transcutaneous - Year-over-year growth 2020-2025 (%)
  • Percutaneous - Market size and forecast 2020-2025 ($ million)
  • Percutaneous - Year-over-year growth 2020-2025 (%)
  • Implantable - Market size and forecast 2020-2025 ($ million)
  • Implantable - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • PNS-TOF - Market size and forecast 2020-2025 ($ million)
  • PNS-TOF - Year-over-year growth 2020-2025 (%)
  • PNS - Market size and forecast 2020-2025 ($ million)
  • PNS - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • Avanos Medical Inc. - Overview
  • Avanos Medical Inc. - Business segments
  • Avanos Medical Inc. - Key offerings
  • Avanos Medical Inc. - Key customers
  • Avanos Medical Inc. - Segment focus
  • B. Braun Melsungen AG - Overview
  • B. Braun Melsungen AG - Business segments
  • B. Braun Melsungen AG - Key offerings
  • B. Braun Melsungen AG - Key customers
  • B. Braun Melsungen AG - Segment focus
  • Bioness Inc. - Overview
  • Bioness Inc. - Product and service
  • Bioness Inc. - Key offerings
  • Bioness Inc. - Key customers
  • Bioness Inc. - Segment focus
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Key customers
  • Boston Scientific Corp. - Segment focus
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • PAJUNK GmbH Medical Technology - Overview
  • PAJUNK GmbH Medical Technology - Product and service
  • PAJUNK GmbH Medical Technology - Key offerings
  • PAJUNK GmbH Medical Technology - Key customers
  • PAJUNK GmbH Medical Technology - Segment focus
  • SPR Therapeutics Inc. - Overview
  • SPR Therapeutics Inc. - Product and service
  • SPR Therapeutics Inc. - Key offerings
  • SPR Therapeutics Inc. - Key customers
  • SPR Therapeutics Inc. - Segment focus
  • SunMed LLC - Overview
  • SunMed LLC - Product and service
  • SunMed LLC - Key offerings
  • SunMed LLC - Key customers
  • SunMed LLC - Segment focus
  • Xavant Technology Pty Ltd. - Overview
  • Xavant Technology Pty Ltd. - Product and service
  • Xavant Technology Pty Ltd. - Key offerings
  • Xavant Technology Pty Ltd. - Key customers
  • Xavant Technology Pty Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global peripheral nerve stimulators market: Abbott Laboratories, Avanos Medical Inc., B. Braun Melsungen AG, Bioness Inc., Boston Scientific Corp., Medtronic Plc, PAJUNK GmbH Medical Technology, SPR Therapeutics Inc., SunMed LLC, and Xavant Technology Pty Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing prevalence of neurologic disorders.'

According to the report, one of the major drivers for this market is the high demand for peripheral nerve stimulators over oral medications.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Bioness Inc.
  • Boston Scientific Corp.
  • Medtronic Plc
  • PAJUNK GmbH Medical Technology
  • SPR Therapeutics Inc.
  • SunMed LLC
  • Xavant Technology Pty Ltd.